Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial
Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page
- Check4 days agoChange DetectedA new revision tag (v3.5.5) was added and the previous tag (v3.5.4) removed, signaling a recent deployment update of the page.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision indicator was updated from v3.5.3 to v3.5.4, signaling a minor administrative update to the page version. No substantive content changes are introduced by this update.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study record itself.SummaryDifference0.0%

- Check54 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded revision tag v3.5.0 and removed revision tag v3.4.3.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, reflecting a minor update to the page version. It does not affect the study content.SummaryDifference0.0%

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.